Skip to main content

Advertisement

Table 1 Clinical background of patients

From: A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors

No. Age (y) Sex Tumor CTV1 (cc) Dose to normal brain (%) [3D-CRT] Dose to normal brain (%) [IMRT] Dose to normal brain (%) [PBT] The relative decrease (%) (3DCRT–PBT)/3DCRT The relative decrease (%) (IMRT–PBT)/IMRT
1 6 M Ependymoma 6.9 11.0 11.5 5.1 53.6 55.7
2 6 M Ependymoma 74.0 20.5 20.1 14.4 29.8 28.4
3 2 F Ependymoma 6.1 17.8 17.1 6.5 63.5 62.0
4 3 F Ependymoma 42.5 30.0 31.8 15.4 48.7 51.6
5 4 M Ependymoma 116.3 48.5 53.1 34.8 28.2 34.5
6 3 F Ependymoma 48.0 27.0 26.9 16.7 38.1 37.9
7 11 M Germinoma 344.8 74.0 72.1 61.2 17.3 15.1
8 16 F Germinoma 150.2 60.5 61.8 48.5 19.8 21.5
9 10 M Germinoma 168.8 54.5 56.3 42.3 22.4 24.9
10 14 M Germinoma 200.6 63.0 62.7 49.2 21.9 21.5
11 14 F Germinoma 216.7 67.0 60.6 55.0 17.9 9.2
12 12 F Germinoma 353.8 62.5 58.9 47.4 24.2 19.5